Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.
Antman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, Bayes De Luna A, Fox K, Lablanche JM, Radley D, Premmereur J, Braunwald E. Antman EM, et al. Among authors: bernink pj. Circulation. 1999 Oct 12;100(15):1593-601. doi: 10.1161/01.cir.100.15.1593. Circulation. 1999. PMID: 10517729 Clinical Trial.
A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction.
Holper EM, Antman EM, McCabe CH, Premmereur J, Gurfinkel E, Bernink PJ, Turpie AG, Bayes de Luna A, Lablanche JM, Fox KM, Salein D, Radley DR, Braunwald E. Holper EM, et al. Among authors: bernink pj. Am J Cardiol. 2001 Apr 15;87(8):1008-10; A5. doi: 10.1016/s0002-9149(01)01440-0. Am J Cardiol. 2001. PMID: 11305997 No abstract available.
Recurrent cardiac ischemic events early after discontinuation of short-term heparin treatment in acute coronary syndromes: results from the Thrombolysis in Myocardial Infarction (TIMI) 11B and Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) studies.
Bijsterveld NR, Peters RJ, Murphy SA, Bernink PJ, Tijssen JG, Cohen M. Bijsterveld NR, et al. Among authors: bernink pj. J Am Coll Cardiol. 2003 Dec 17;42(12):2083-9. doi: 10.1016/j.jacc.2003.05.014. J Am Coll Cardiol. 2003. PMID: 14680731 Clinical Trial.
Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: the MACH-1 study. Mortality Assessment in Congestive Heart Failure Trial.
Levine TB, Bernink PJ, Caspi A, Elkayam U, Geltman EM, Greenberg B, McKenna WJ, Ghali JK, Giles TD, Marmor A, Reisin LH, Ammon S, Lindberg E. Levine TB, et al. Among authors: bernink pj. Circulation. 2000 Feb 22;101(7):758-64. doi: 10.1161/01.cir.101.7.758. Circulation. 2000. PMID: 10683349 Clinical Trial.
28 results